Mesa Laboratories (MLAB) Liabilities and Shareholders Equity (2011 - 2025)

Mesa Laboratories has disclosed Liabilities and Shareholders Equity across 15 years of filings, most recently posting $434.8 million for Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $434.8 million, changed 0.35% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 billion (down 2.27% YoY), and the FY2025 annual result was $433.3 million, down 3.01% from the prior year.
• Liabilities and Shareholders Equity came in at $434.8 million for Q4 2025 at Mesa Laboratories, up from $430.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $741.8 million in Q4 2023 to a low of $430.4 million in Q3 2025.
• The 5-year median for Liabilities and Shareholders Equity is $610.8 million (2021), against an average of $572.5 million.
• Across the five-year window, Liabilities and Shareholders Equity surged 47.02% in 2021 and slumped 41.58% in 2024, its largest moves.
• Mesa Laboratories' Liabilities and Shareholders Equity stood at $721.7 million in 2021, then slipped by 8.14% to $663.0 million in 2022, then increased by 11.88% to $741.8 million in 2023, then plunged by 41.58% to $433.3 million in 2024, then grew by 0.35% to $434.8 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $434.8 million (Q4 2025), $430.4 million (Q3 2025), and $435.7 million (Q2 2025), per Business Quant data.